Table 1. Basic information for included studies of the association between IFNG +874 T/A (rs2430561) polymorphism site and tuberculosis susceptibility.
First author | Year | Origin | Source of Control | Ethnicity | Type | Sample size | Case | Control | Case | Control | Control | Methods | NOS | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ref No | TT | TA | AA | MAF | HWE | TT | TA | AA | MAF | HWE | ||||||||||||||
Amim*[34] | 2008 | Brazil | HB | Mixed | TB | <100 | 93 | 266 | 15 | 25 | 53 | 0.296 | 0.0006 | 67 | 88 | 111 | 0.417 | 0.001 | PCR-ARMS | 6 | ||||
Anand[21] | 2010 | India | HB | Asian | PTB | <100 | 62 | 66 | 7 | 27 | 28 | 0.331 | 0.898 | 8 | 25 | 33 | 0.311 | 0.35 | PCR-ASP | 6 | ||||
Ansari*[53] | 2009 | Pakistan | HB | Asian | PTB | >100 | 111 | 188 | 27 | 47 | 37 | 0.455 | 0.123 | 25 | 87 | 76 | 0.364 | 0.98 | PCR-ARMS | 7 | ||||
Ansari*[53] | 2009 | Pakistan | HB | Asian | EPTB | <100 | 77 | 188 | 12 | 36 | 29 | 0.389 | 0.881 | 25 | 87 | 76 | 0.364 | 0.98 | PCR-ARMS | 7 | ||||
Anuradha*[27] | 2008 | India | PB | Asian | Children TB | <100 | 25 | 90 | 5 | 13 | 7 | 0.46 | 0.815 | 29 | 42 | 19 | 0.555 | 0.6 | PCR | 6 | ||||
Asgharzadeh[64] | 2016 | Iran | PB | Asian | TB | >100 | 124 | 200 | 10 | 42 | 72 | 0.25 | 0.281 | 28 | 81 | 91 | 0.342 | 0.15 | PCR-ARMS | 8 | ||||
Bhanothu[47] | 2015 | India | HB | Asian | EPTB | >100 | 175 | 100 | 45 | 87 | 43 | 0.506 | 0.941 | 29 | 62 | 9 | 0.6 | 0.003 | ARMS-MG/ MP-PCR |
6 | ||||
Cooke*[36] | 2006 | UK | PB | African | PTB | >100 | 667 | 597 | 20 | 159 | 488 | 0.149 | 0.115 | 13 | 166 | 415 | 0.162 | 0.45 | PCR-ARMS | 6 | ||||
Ding*[26] | 2008 | China | PB | Asian | TB | >100 | 301 | 310 | 19 | 89 | 193 | 0.211 | 0.052 | 32 | 114 | 164 | 0.287 | 0.07 | sequencing | 8 | ||||
Etokebe*[40] | 2005 | Croatia | HB | Caucasian | TB | >100 | 242 | 519 | 53 | 122 | 67 | 0.471 | 0.637 | 103 | 282 | 134 | 0.47 | 0.04 | PCR-ASP | 6 | ||||
Fitness*[48] | 2004 | Malawi | PB | African | TB | >100 | 451 | 703 | 12 | 134 | 305 | 0.175 | 0.549 | 17 | 219 | 467 | 0.179 | 0.14 | PCR-ARMS | 8 | ||||
Gutlapalli[32] | 2016 | India | HB | Asian | TB | >100 | 247 | 129 | 73 | 123 | 51 | 0.544 | 0.951 | 60 | 58 | 11 | 0.689 | 0.56 | PCR-ARMS | 6 | ||||
Hashemi[20] | 2011 | Iran | PB | Asian | PTB | >100 | 142 | 166 | 18 | 84 | 40 | 0.422 | 0.011 | 33 | 111 | 22 | 0.533 | 0.001 | PCR-ARMS | 7 | ||||
Hu[45] | 2015 | China | PB | Asian | TB | >100 | 360 | 480 | 36 | 124 | 200 | 0.272 | 0.013 | 67 | 201 | 212 | 0.349 | 0.08 | PCR-ARMS | 7 | ||||
Hwang*[50] | 2007 | Korea | PB | Asian | PTB | <100 | 80 | 80 | 1 | 13 | 66 | 0.094 | 0.696 | 0 | 21 | 59 | 0.131 | 0.17 | PCR-ARMS | 7 | ||||
Leandro[43] | 2013 | Brazil | PB | Mixed | TB | >100 | 172 | 179 | 22 | 78 | 72 | 0.354 | 0.902 | 26 | 91 | 62 | 0.399 | 0.42 | PCR-ARMS | 8 | ||||
Lee[44] | 2015 | Taiwan | PB | Asian | TB | >100 | 200 | 202 | 131 | 56 | 13 | 0.795 | 0.046 | 144 | 54 | 4 | 0.846 | 0.68 | TaqMan | 8 | ||||
Lio[9] | 2002 | Italy | PB | Caucasian | PTB | <100 | 45 | 97 | 4 | 30 | 11 | 0.422 | 0.013 | 25 | 47 | 25 | 0.5 | 0.06 | PCR-ARMS | 8 | ||||
Lopez- Maderuelo*[39] |
2003 | Spain | PB | Caucasian | PTB | >100 | 113 | 100 | 11 | 40 | 62 | 0.274 | 0.238 | 19 | 50 | 31 | 0.44 | 0.88 | PCR | 6 | ||||
Ma*[49] | 2007 | China | PB | Asian | PTB | <100 | 60 | 60 | 2 | 10 | 48 | 0.117 | 0.138 | 8 | 20 | 32 | 0.3 | 0.11 | PCR-SSP | 6 | ||||
Mabunda[29] | 2015 | Brazil | HB | Mixed | PTB | >100 | 101 | 360 | 3 | 32 | 66 | 0.188 | 0.708 | 21 | 136 | 203 | 0.247 | 0.77 | TaqMan | 7 | ||||
Moran*[30] | 2007 | USA | PB | African | TB | >100 | 240 | 174 | 9 | 87 | 144 | 0.219 | 0.348 | 11 | 65 | 98 | 0.25 | 0.96 | sequencing | 7 | ||||
Moran*[30] | 2007 | USA | PB | Caucasian | TB | <100 | 161 | 64 | 24 | 92 | 45 | 0.435 | 0.039 | 16 | 31 | 17 | 0.492 | 0.8 | sequencing | 7 | ||||
Moran*[30] | 2007 | USA | PB | Caucasian | TB | <100 | 319 | 98 | 24 | 96 | 199 | 0.226 | 0.013 | 10 | 26 | 62 | 0.235 | 0.01 | sequencing | 7 | ||||
Mosaad[42] | 2010 | Egypt | HB | Caucasian | TB | >100 | 110 | 118 | 32 | 60 | 18 | 0.563 | 0.253 | 52 | 60 | 6 | 0.695 | 0.03 | PCR-ARMS | 6 | ||||
Onay*[22] | 2010 | Turkey | HB | Caucasian | Children TB | <100 | 40 | 67 | 9 | 22 | 9 | 0.5 | 0.527 | 16 | 35 | 16 | 0.5 | 0.71 | PCR-ARMS | 6 | ||||
Oral*[35] | 2006 | Turkey | PB | Caucasian | TB | <100 | 81 | 50 | 21 | 29 | 31 | 0.438 | 0.014 | 8 | 21 | 21 | 0.37 | 0.48 | PCR-SSP | 8 | ||||
Rossouw*[38] | 2003 | UK | PB | African | TB | >100 | 313 | 235 | 25 | 102 | 186 | 0.243 | 0.078 | 26 | 98 | 111 | 0.319 | 0.53 | PCR | 6 | ||||
Sallakci*[33] | 2007 | Turkey | HB | Caucasian | TB | >100 | 361 | 115 | 50 | 182 | 129 | 0.391 | 0.262 | 26 | 58 | 31 | 0.478 | 0.91 | sequencing | 6 | ||||
Selma*[25] | 2011 | Tunisia | PB | African | TB | >100 | 223 | 150 | 38 | 85 | 100 | 0.361 | 0.009 | 22 | 86 | 42 | 0.433 | 0.04 | PCR-RFLP | 7 | ||||
Selvaraj*[52] | 2008 | India | HB | Asian | PTB | >100 | 160 | 178 | 20 | 72 | 68 | 0.35 | 0.889 | 23 | 76 | 79 | 0.342 | 0.48 | PCR-RFLP | 7 | ||||
Shen[28] | 2013 | China | PB | Asian | Children TB | >100 | 189 | 164 | 136 | 53 | 0 | 0.859 | 0.024 | 133 | 29 | 2 | 0.899 | 0.77 | sequencing | 6 | ||||
Tso*[37] | 2005 | Hong Kong | HB | Asian | TB | >100 | 385 | 451 | 17 | 101 | 267 | 0.175 | 0.068 | 55 | 190 | 206 | 0.332 | 0.28 | sequencing | 6 | ||||
Vallinoto*[23] | 2010 | Brazil | PB | Mixed | TB | >100 | 162 | 156 | 11 | 58 | 93 | 0.247 | 0.635 | 24 | 86 | 46 | 0.429 | 0.12 | PCR-ASO | 7 | ||||
Vidyarani*[31] | 2006 | India | HB | Asian | PTB | >100 | 129 | 127 | 14 | 54 | 61 | 0.318 | 0.694 | 20 | 52 | 55 | 0.362 | 0.2 | PCR-ARMS | 6 | ||||
Wang*[54] | 2011 | China | HB | Asian | PTB | >100 | 273 | 297 | 3 | 78 | 192 | 0.154 | 0.107 | 3 | 84 | 210 | 0.151 | 0.08 | PCR-RFLP | 6 | ||||
Wang*[24] | 2010 | China | PB | Asian | PTB | >100 | 521 | 526 | 14 | 80 | 427 | 0.104 | <0.001 | 10 | 91 | 425 | 0.105 | 0.06 | PCR-RFLP | 6 | ||||
Wit*[51] | 2011 | South Africa | PB | Mixed | TB | >100 | 500 | 315 | 40 | 194 | 266 | 0.274 | 0.579 | 33 | 124 | 158 | 0.301 | 0.24 | PCR-RFLP | 6 | ||||
Wu*[41] | 2008 | China | PB | Asian | PTB | <100 | 61 | 122 | 1 | 10 | 50 | 0.098 | 0.554 | 2 | 24 | 96 | 0.114 | 0.72 | PCR-RFLP | 8 | ||||
Yang*[57] | 2010 | China | HB | Asian | PTB | >100 | 189 | 191 | 6 | 41 | 142 | 0.14 | 0.168 | 3 | 49 | 139 | 0.143 | 0.57 | PCR-SSP | 6 | ||||
Zhong[55] | 2014 | China | HB | Asian | PTB | >100 | 142 | 166 | 4 | 26 | 112 | 0.119 | 0.117 | 7 | 49 | 110 | 0.189 | 0.61 | TaqMan | 6 | ||||
Zhuang[56] | 2009 | China | HB | Asian | PTB | >100 | 167 | 167 | 12 | 53 | 102 | 0.231 | 0.172 | 37 | 70 | 60 | 0.431 | 0.06 | PCR-SSP | 5 |
HWE: Hardy–Weinberg equilibrium; HB: hospital-based; PB: population-based; TB: tuberculosis; PTB: pulmonary TB, EPTB: extra-pulmonary TB; PCR-FLIP: polymerase chain reaction and restrictive fragment length polymorphism; PCR-ARMS: polymerase chain reaction-amplification refractory mutation specific; PCR-ASP: allele specific primers by polymerase chain reaction, PCR-SSP: polymerase chain reaction-sequence specific primer; PCR-ASO: polymerase chain reaction-allele-specific oligonucleotide; ARMS-MG/MP-PCR: Amplification refractory mutation system-multi gene/multi primer polymerase chain reaction; NOS: Newcastle-Ottawa Scale; *: studies reported in previous meta-analysis; bold: these nine studies including both PTB and EPTB.